For patients with chronic kidney disease and type 2 diabetes, combination finerenone plus empagliflozin leads to a greater ...

Phase II CONFIDENCE study data reveal that simultaneous initiation of Kerendia and Jardiance significantly improves UACR and ...

Prompt treatment with a drug combo can effectively manage chronic kidney disease in people with type 2 diabetes, a new ...

Simultaneous treatment start with finerenone and SGLT-2-inhibitor demonstrated positive data in patients with CKD associated with type 2 diabetes: Berlin Saturday, June 7, 2025, 1 ...

The standard of care for managing patients with type 2 diabetes and CKD -- in addition to a healthy lifestyle -- has always ...

Patients with macroalbuminuria faced a significantly higher risk of major adverse cardiovascular events (MACE), heart failure ...

A new microfluidic device promises to revolutionize kidney disease screening by enabling rapid, accurate, and low-cost testing of creatinine levels ...

Kidney function tests are simple medical tests that help doctors check if your kidneys are doing their job properly. These tests can show early signs of kidney problems even before you notice any ...

In acute kidney injury, certain biomarkers—such as urine albumin-to-creatinine ratio and epidermal growth factor—are linked with likelihood of eGFR nonrecovery.

Study reveals semaglutide’s potential in lowering elevated urine albumin levels in overweight chronic kidney disease patients. Study: Semaglutide in patients with overweight or obesity and ...

Risk for all-cause mortality increased in RA patients with microalbuminuria. (HealthDay News) — For patients with rheumatoid arthritis (RA), urine albumin-to-creatinine ratio (ACR) is an ...

THURSDAY, Oct. 10, 2024 (HealthDay News) -- For patients with rheumatoid arthritis (RA), urine albumin-to-creatinine ratio (ACR) is an independent risk factor indicating prognosis, according to a ...